官方服务：
资源简介：
*compared with 1st dose (23vPPV), **compared with 1st dose (PCV7).
应用场景：
创建时间：
2014-04-23
相关数据集
Neurological Adverse Events Post Vaccination
Retrospective results from VAERS database on neurological adverse events
DataONE2023-11-14 更新70
Local and systemic solicited adverse events (AEs) Day 0 through Day 7.
Organized by AMA-1 dose and Adjuvant Group, AEs solicited post immunization with highest grade reported. Reported by percentage experiencing AE, with percent experiencing Grade 3 in parentheses. Imm =
NIAID Data Ecosystem30
Immediate and delayed adverse events after the first and second vaccinations.
Immediate and delayed adverse events after the first and second vaccinations.
NIAID Data Ecosystem20
sj-xlsx-2-cath-10.1177_10760296211068487 - Supplemental material for Thrombosis with Thrombocytopenia Syndrome After Administration of AZD1222 or Ad26.COV2.S Vaccine for COVID-19: A Systematic Review
Supplemental material, sj-xlsx-2-cath-10.1177_10760296211068487 for Thrombosis with Thrombocytopenia Syndrome After Administration of AZD1222 or Ad26.COV2.S Vaccine for COVID-19: A Systematic Review b
DataCite Commons2024-08-28 更新50
Local and Systemic Adverse Events Within 3 days After Receipt of Vaccination, According to Group.
aThese adverse events were not evaluated among rheumatoid arthritis patients.
Figshare2015-12-02 更新20
